These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18369969)

  • 1. Drug delivery in cancer using liposomes.
    Dass CR
    Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active drug targeting: drug delivery to tumors as an example.
    Torchilin VP
    Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy].
    Kunisawa J; Mayumi T
    Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
    Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterically stabilized liposomes in cancer therapy and gene delivery.
    Lasic DD; Vallner JJ; Working PK
    Curr Opin Mol Ther; 1999 Apr; 1(2):177-85. PubMed ID: 11715941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive liposomes--principle and application in cancer therapy.
    Karanth H; Murthy RS
    J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-based drug delivery systems.
    Langner M; Kral TE
    Pol J Pharmacol; 1999; 51(3):211-22. PubMed ID: 10600035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
    Kaneda Y
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano- or submicron-sized liposomes as carriers for drug delivery.
    Fang JY
    Chang Gung Med J; 2006; 29(4):358-62. PubMed ID: 17051832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal cancer therapy: exploiting tumor characteristics.
    Kaasgaard T; Andresen TL
    Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptor.
    Corona-Ortega T; Rangel-Corona R; Hernández-Jiménez M; Baeza I; Ibáñez M; Weiss-Steider B
    J Drug Target; 2009 Aug; 17(7):496-501. PubMed ID: 19514860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
    Shenoy VS; Vijay IK; Murthy RS
    J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of high molecular weight agents.
    Cassidy J; Newell DR; Wedge SR; Cummings J
    Cancer Surv; 1993; 17():315-41. PubMed ID: 8137346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
    Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
    Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect.
    Hiraka K; Kanehisa M; Tamai M; Asayama S; Nagaoka S; Oyaizu K; Yuasa M; Kawakami H
    Colloids Surf B Biointerfaces; 2008 Nov; 67(1):54-8. PubMed ID: 18775654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive liposomes for drug delivery in cancer treatment.
    Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
    Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.